Sarah Hull1, Nicholas Owen2, Farrah Islam3, Dhani Tracey-White2, Vincent Plagnol4, Graham E Holder1, Michel Michaelides1, Keren Carss5, F Lucy Raymond6, Jean-Michel Rozet7, Simon C Ramsden8, Graeme C M Black9, Isabelle Perrault7, Ajoy Sarkar10, Mariya Moosajee1, Andrew R Webster1, Gavin Arno1, Anthony T Moore11. 1. University College London Institute of Ophthalmology, London, United Kingdom 2Moorfields Eye Hospital, London, United Kingdom. 2. University College London Institute of Ophthalmology, London, United Kingdom. 3. Moorfields Eye Hospital, London, United Kingdom 3Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan. 4. University College London Genetics Institute, London, United Kingdom. 5. Department of Haematology, University of Cambridge, Cambridge, United Kingdom 6NIHR BioResource-Rare Diseases, Department of Haematology, University of Cambridge, Cambridge, United Kingdom. 6. NIHR BioResource-Rare Diseases, Department of Haematology, University of Cambridge, Cambridge, United Kingdom 7Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom. 7. Laboratory of Genetics in Ophthalmology, INSERM UMR 1163, Paris Descartes-Sorbonne University, Imagine Institut, Paris, France. 8. Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, St Mary's Hospital, Manchester, United Kingdom. 9. Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, St Mary's Hospital, Manchester, United Kingdom 10Manchester Centre for Genomic Medicine, Institute of Human D. 10. Department of Clinical Genetics, Nottingham City Hospital, Nottingham, United Kingdom. 11. University College London Institute of Ophthalmology, London, United Kingdom 2Moorfields Eye Hospital, London, United Kingdom 12Ophthalmology, University of California, San Francisco, California, United States.
Abstract
PURPOSE: Mutations in the ciliary transporter gene IFT140, usually associated with a severe syndromic ciliopathy, may also cause isolated retinal dystrophy. A series of patients with nonsyndromic retinitis pigmentosa (RP) due to IFT140 was investigated in this study. METHODS: Five probands and available affected family members underwent detailed phenotyping including retinal imaging and electrophysiology. Whole exome sequencing was performed on two probands, a targeted sequencing panel of 176 retinal genes on a further two, and whole genome sequencing on the fifth. Missense mutations of IFT140 were further investigated in vitro using transient plasmid transfection of hTERT-RPE1 cells. RESULTS: Eight affected patients from five families had preserved visual acuity until at least the second decade; all had normal development without skeletal manifestations or renal failure at age 13 to 67 years (mean, 42 years; median, 44.5 years). Bi-allelic mutations in IFT140 were identified in all families including two novel mutations: c.2815T > C (p.Ser939Pro) and c.1422_23insAA (p.Arg475Asnfs*14). Expression studies demonstrated a significantly reduced number of cells showing localization of mutant IFT140 with the basal body for two nonsyndromic mutations and two syndromic mutations compared with the wild type and a polymorphism. CONCLUSIONS: This study highlights the phenotype of nonsyndromic RP due to mutations in IFT140 with milder retinal dystrophy than that associated with the syndromic disease.
PURPOSE: Mutations in the ciliary transporter gene IFT140, usually associated with a severe syndromic ciliopathy, may also cause isolated retinal dystrophy. A series of patients with nonsyndromic retinitis pigmentosa (RP) due to IFT140 was investigated in this study. METHODS: Five probands and available affected family members underwent detailed phenotyping including retinal imaging and electrophysiology. Whole exome sequencing was performed on two probands, a targeted sequencing panel of 176 retinal genes on a further two, and whole genome sequencing on the fifth. Missense mutations of IFT140 were further investigated in vitro using transient plasmid transfection of hTERT-RPE1 cells. RESULTS: Eight affected patients from five families had preserved visual acuity until at least the second decade; all had normal development without skeletal manifestations or renal failure at age 13 to 67 years (mean, 42 years; median, 44.5 years). Bi-allelic mutations in IFT140 were identified in all families including two novel mutations: c.2815T > C (p.Ser939Pro) and c.1422_23insAA (p.Arg475Asnfs*14). Expression studies demonstrated a significantly reduced number of cells showing localization of mutant IFT140 with the basal body for two nonsyndromic mutations and two syndromic mutations compared with the wild type and a polymorphism. CONCLUSIONS: This study highlights the phenotype of nonsyndromic RP due to mutations in IFT140 with milder retinal dystrophy than that associated with the syndromic disease.
Authors: Cristy A Ku; Sarah Hull; Gavin Arno; Ajoy Vincent; Keren Carss; Robert Kayton; Douglas Weeks; Glenn W Anderson; Ryan Geraets; Camille Parker; David A Pearce; Michel Michaelides; Robert E MacLaren; Anthony G Robson; Graham E Holder; Elise Heon; F Lucy Raymond; Anthony T Moore; Andrew R Webster; Mark E Pennesi Journal: JAMA Ophthalmol Date: 2017-07-01 Impact factor: 7.389
Authors: Sarah R Senum; Ying Sabrina M Li; Katherine A Benson; Giancarlo Joli; Eric Olinger; Sravanthi Lavu; Charles D Madsen; Adriana V Gregory; Ruxandra Neatu; Timothy L Kline; Marie-Pierre Audrézet; Patricia Outeda; Cherie B Nau; Esther Meijer; Hamad Ali; Theodore I Steinman; Michal Mrug; Paul J Phelan; Terry J Watnick; Dorien J M Peters; Albert C M Ong; Peter J Conlon; Ronald D Perrone; Emilie Cornec-Le Gall; Marie C Hogan; Vicente E Torres; John A Sayer; Peter C Harris Journal: Am J Hum Genet Date: 2021-12-09 Impact factor: 11.043
Authors: Keren J Carss; Gavin Arno; Marie Erwood; Jonathan Stephens; Alba Sanchis-Juan; Sarah Hull; Karyn Megy; Detelina Grozeva; Eleanor Dewhurst; Samantha Malka; Vincent Plagnol; Christopher Penkett; Kathleen Stirrups; Roberta Rizzo; Genevieve Wright; Dragana Josifova; Maria Bitner-Glindzicz; Richard H Scott; Emma Clement; Louise Allen; Ruth Armstrong; Angela F Brady; Jenny Carmichael; Manali Chitre; Robert H H Henderson; Jane Hurst; Robert E MacLaren; Elaine Murphy; Joan Paterson; Elisabeth Rosser; Dorothy A Thompson; Emma Wakeling; Willem H Ouwehand; Michel Michaelides; Anthony T Moore; Andrew R Webster; F Lucy Raymond Journal: Am J Hum Genet Date: 2016-12-29 Impact factor: 11.025
Authors: Brooke L Latour; Zeineb Bakey; Ronald Roepman; Ernie M H F Bongers; Machteld M Oud; Stef J Letteboer; Dorien Lugtenberg; Ka Man Wu; Elisabeth A M Cornelissen; Helger G Yntema; Miriam Schmidts Journal: Cilia Date: 2018-02-23
Authors: Basamat Almoallem; Gavin Arno; Julie De Zaeytijd; Hannah Verdin; Irina Balikova; Ingele Casteels; Thomy de Ravel; Sarah Hull; Martina Suzani; Anne Destrée; Michelle Peng; Denise Williams; John R Ainsworth; Andrew R Webster; Bart P Leroy; Anthony T Moore; Elfride De Baere Journal: Sci Rep Date: 2020-01-28 Impact factor: 4.379
Authors: Gabrielle Wheway; N Simon Thomas; Mary Carroll; Janice Coles; Regan Doherty; Patricia Goggin; Ben Green; Amanda Harris; David Hunt; Claire L Jackson; Jenny Lord; Vito Mennella; James Thompson; Woolf T Walker; Jane S Lucas Journal: BMC Med Genomics Date: 2021-09-23 Impact factor: 3.063
Authors: Benjamin M Helm; Jason R Willer; Azita Sadeghpour; Christelle Golzio; Eric Crouch; Samantha Schrier Vergano; Nicholas Katsanis; Erica E Davis Journal: Hum Genomics Date: 2017-07-19 Impact factor: 4.639